Professor Anna Ralph
Deputy Director (Research); Senior Principal Research Fellow
Qualifications:
PhD, Australian National University, 2010; Fellow of the Royal Australasian College of Physicians, 2005; Diploma of Hygiene and Tropical Medicine, University of London, 2002; Master of Public Health, University of Sydney, 1999; Bachelor of Medicine and Bachelor of Surgery Honours Class 1, University of New South Wales, 1996; Medical Science Honours Class 1, Australian National University, 1993; Bachelor of Medical Science, University of Tasmania, 1992.
Approved level of HDR supervision at Charles Darwin University:
Supervisor for PhD
Location:
Darwin - Royal Darwin Hospital campus
Biography:
Professor Anna Ralph is a Senior Principal Research Fellow with the Global and Tropical Health Division at Menzies School of Health Research, Darwin, Northern Territory, Australia. She shares the role of Deputy Director of Research with Prof Louise Maple-Brown. She is also a practising medical specialist in General Medicine and Infectious Diseases at Royal Darwin Hospital and Palmerston Regional Hospital.
Her research fields include Australian tropical infectious diseases, rheumatic fever and rheumatic heart disease in Australian Indigenous populations, tuberculosis control especially in neighbouring South-East Asian settings, and improving cultural safety in healthcare. She has expertise in a broad range of research methods.
Professor Ralph’s roles include membership of the Medical Journal of Australia’s Editorial Advisory Committee, the Northern Territory Government Department of Health (NT Health) Top End Division of Medicine Research Committee, NT Health Aboriginal Health Committee, CARPA Standard Treatment Manual editorial committee, the NT RHD Control Program Steering Committee and she is a fellows of the Australasian Society for Infectious Diseases.
She supervises a number of PhD students, post doctoral researchers, and Advanced Trainees in Infectious Diseases through the Royal Australasian College of Physicians.
Current Projects
- The Communicate Study
- RHDAustralia
- Searching for a Technology-driven Acute Rheumatic fever Test (START)
- STopping Acute Rheumatic Fever Infections to Strengthen Health: STARFISH
- Check4Strep
- PRIME-TB - Papua New Guinea & Indonesia for the Micro Elimination of TB
- CONTRA TB - a tool to scale up TB contract tracing in a high burden setting
- PRIME-TB - Papua New Guinea & Indonesia for the Micro Elimination of TB
- Secondary Prophylaxis Plus (SPPlus: expanding RHD prevention
Past Projects
- HOT NORTH
- The Tuberculosis Centre of Research Excellence
- The Tropical Disease Regional Research Collaborative Initiative (TDRRCI)
- Tuberculosis
- Strengthening health systems to improve the delivery of tuberculosis contact investigation and preventive therapy in Timika (Indonesia) and Kota Kinabalu (Malaysia)
- Embedding sustained improvements in TB diagnosis and management into practice in eastern Malaysia
- Understanding the molecular epidemiology of TB in Sabah, Malaysia
- Improving the diagnosis of ARF
- Enhanced models of secondary prevention for RHD
- On Track Watch: a grassroots Rheumatic Heart Disease initiative in the Northern Territory
- Determinants and outcomes of adherence to secondary prophylaxis for ARF
- Improving delivery of secondary prophylaxis for rheumatic heart disease: a stepped-wedge, community-randomised trial (2012-2016).
- Kerrigan V, McGrath SY, Majoni SW, Walker M, Ahmat M, Lee B, Cass A, Hefler M, Ralph AP. From “stuck” to satisfied: Aboriginal people’s experience of culturally safe care with interpreters in a Northern Territory hospital. BMC Health Services Research, 2021. doi: 10.1186/s12913-021-06564-4
- Meumann EM, Horna K, Ralph AP, Framer B, Globan M, Stephenson E, Popple T, Boyd R, Kaestli M, Seemann T, Vandelannoote K, Lowbridge C, Barid R, Stinear T, Williamson D, Currie BJ, Krause VL. Tuberculosis in Australia's tropical north: a population-based genomic epidemiological study. The Lancet Regional Health Volume 15, 100229, October 01, 2021. doi:10.1016/j.lanwpc.2021.100229
- Ralph AP, Noonan S, Wade V, Currie BJ. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. MJA 2020. doi:10.5694/mja2.50851. 2020
- Tong SYC, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J, Archuleta S, Roberts MA, Cass A, Paterson DL, Foo H, Paul M, Guy SD, Tramontana AR, Walls GB, McBride S, Bak N, Ghosh N, Rogers BA, Ralph AP…O'Sullivan M, Davis JS. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. JAMA. 2020;323:527-537. doi: 10.1001/jama.2020.0103.
- Haynes E, Marawili M, Marika BM, Mitchell AG, Phillips J, Bessarab D, Walker R, Cooke J, Ralph AP. Community-based participatory action research on rheumatic heart disease in an Australian Aboriginal homeland: Evaluation of the ‘On track watch’ project. Eval Program Plann. 2019; 74:38– doi.org/10.1016/j.evalprogplan.2019.02.010.
- de Dassel JL, de Klerk N, Carapetis JR, Ralph AP. How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease. J Am Heart Assoc. 2018;7(24):e010223. doi: 10.1161/JAHA.118.010223.
- Ralph AP, de Dassel JL, Kirby A, Read C, Mitchell AG, Maguire GP, Currie BJ, Bailie RS, Johnston V, Carapetis JR. Improving delivery of secondary prophylaxis for rheumatic heart disease: outcome of a stepped-wedge, community, randomized trial. JAHA; 2018: 7:e009308. doi: 10.1161/JAHA.118.009308.
- He V, Condon J, Ralph AP, Zhao Y, Roberts K, de Dassel J, Currie BJ, Fittock M, Edwards K, Carapetis J. Long-Term Outcomes from Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach. Circulation. 2016; 134:222-32.
- Ralph AR, Carapetis JR. Group A Streptococcal diseases and their global burden. Curr Top Microbiol Immunol (Host-pathogen interactions in streptococcal diseases). 2013;368:1-27. doi: 10.1007/82_2012_280., 1-27.
- Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, et al. L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS ONE. 2013;8(8):e70032. doi: 10.1371/journal.pone.0070032